Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.8.0.1
Consolidated Statements of Operations - USD ($)
 12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Income Statement [Abstract]    
Product revenue $ 11,227,000 $ 15,226,000
Costs of revenue 6,352,000 3,777,000
Gross profit 4,876,000 11,449,000
Operating expenses:    
Research and development 5,077,000 6,345,000
General and administrative 4,380,000 6,292,000
Sales and marketing 6,472,000 10,347,000
Total operating expenses 15,929,000 22,984,000
Loss from operations (11,053,000) (11,535,000)
Other income (expenses):    
Interest expense (1,263,000) (4,511,000)
Loss on extinguishment of debt (661,000)
Change in fair value of derivative liabilities 3,118,000 2,476,000
Offering costs (131,000) (571,000)
Other income 39,000
Total other income (expense), net 1,724,000 (3,228,000)
Net loss before income taxes (9,329,000) (14,763,000)
Provision for income taxes
Net loss (9,329,000) (14,763,000)
Deemed dividend related to beneficial conversion feature and accretion of discount on convertible series A preferred stock (6,278,000)
Net loss attributable to common stockholders $ (9,329,000) $ (21,041,000)
Net loss per share attributable to common stockholders:    
Basic and diluted $ (3.13) $ (13.63)
Weighted average common shares outstanding:    
Basic and diluted 2,978,904 1,543,735